Finnzymes
Acquisitions in the past few years have enriched Thermo Fisher's portfolio of PCR platforms, but the firm says the PikoReal is not being developed for IVD use.
EU-Funded Consortium Looks to Move Blood-based, Lateral Flow Malaria MDx to Commercial Development
Premium
A public-private consortium formed to investigate multi-drug resistance in malaria this week reached the end of a five-year, €2.8 million (about $3.6 million) project having identified a number of genetic markers related to drug resistance and developed a highly sensitive and spe
A study published this week provides the most definitive evidence to date disproving previous reports that used molecular testing methods such as qPCR to establish a link between chronic fatigue syndrome, or myalgic encephalomyelitis, and various murine leukemia viruses.
The Piko thermal cycler was previously commercially available from Finnzymes, but is now being sold under the Thermo Fisher brand. Meantime, the Arktik thermal cycler is not yet commercially available, but is expected to be by Q4 of this year.
Jun 3, 2010
May 27, 2010
Mar 10, 2010
Mar 5, 2010
Thermo Fisher Completes Finnzymes Acquisition
Feb 4, 2010
Dec 10, 2009